Cancer Gene Therapy
Ovarian cancer gene transfer treatment evaluated in a xenograft model
Published in Women's Health Weekly, November 9th, 2006
"Abnormalities in the p53 and p16 tumor suppressor genes are one of the most common occurrences associated with human neoplasia. Consequently, restoration of wild-type p53 or p16 functions is seen as a particularly promising approach for cancer gene therapy. In vitro and in vivo data have demonstrated that virus-mediated p53 gene transfer can induce active cell death and ovarian tumor regression," wrote P. Collinet and colleagues, University of Lille.
They continued...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Hormone Therapy
Study finds estrogen loss affects the brain's ability to process emotional - Ovarian Cancer
Ovarian cancer proliferation and angiogenesis diminish upon Src inhibition - Premenstrual Syndrome
Low doses of anti-depressants may be effective treatment for premenstrual syndrome - Uterine Cancer
Study reveals unique P2X7 biomarker for early cancer detection - Adenoid Cystic Cancer Immunology
Studies from University of California, Department of Pathology in the area of adenoid cystic cancer immunology described - Breast Cancer
Data on breast cancer reported by researchers at University of Aberdeen - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
